| Mrs Mary K Holzinger, LCSW-C, CEAP | |
|
164 W Main St, Suite A, New Market, MD 21774 | |
| (301) 865-2226 | |
| Not Available |
| Full Name | Mrs Mary K Holzinger |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 34 Years |
| Location | 164 W Main St, New Market, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497805808 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 10889 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Linganore Counseling And Wellness Llc | 1951527456 | 6 |
News Archive
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that its ToleroMune(R) ragweed allergy T-cell vaccine achieved positive results in a recently completed phase II clinical trial. Ragweed allergy is particularly common in America, where it affects approximately 25% of the population. Circassia's latest clinical results follow two earlier successful phase II studies with the company's T-cell vaccine against cat allergy.
New research shows that patients who have had contact with the hospital due to serious glandular disease have a greater risk of subsequently developing depression.
Ablynx [Euronext Brussels: ABLX] and Spirogen Ltd. announce a research collaboration to evaluate the potential of a novel anti-cancer drug conjugate combining Spirogen's proprietary cytotoxic drugs, pyrrolobenzodiazepines (PBD), and associated linker technology, with Nanobodies® generated using Ablynx's proprietary technology platform.
Final results of the randomized intergroup EORTC, LYSA (Lymphoma Study Association), FIL (Fondazione Italiana Linfomi) H10 trial presented at the 13th International Conference on Malignant Lymphoma in Lugano, Switzerland, on 19 June 2015 show that early FDG-PET ( 2-deoxy-2[F-18]fluoro-D-glucose positron emission tomography) adapted treatment improves the outcome of early FDG-PET-positive patients with stages I/II Hodgkin lymphoma.
Heart failure is a medical condition that results when the heart muscle is not strong enough to effectively circulate blood.
› Verified 1 days ago
| Entity Name | Linganore Counseling And Wellness Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174956965 PECOS PAC ID: 1951527456 Enrollment ID: O20140718000370 |
News Archive
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that its ToleroMune(R) ragweed allergy T-cell vaccine achieved positive results in a recently completed phase II clinical trial. Ragweed allergy is particularly common in America, where it affects approximately 25% of the population. Circassia's latest clinical results follow two earlier successful phase II studies with the company's T-cell vaccine against cat allergy.
New research shows that patients who have had contact with the hospital due to serious glandular disease have a greater risk of subsequently developing depression.
Ablynx [Euronext Brussels: ABLX] and Spirogen Ltd. announce a research collaboration to evaluate the potential of a novel anti-cancer drug conjugate combining Spirogen's proprietary cytotoxic drugs, pyrrolobenzodiazepines (PBD), and associated linker technology, with Nanobodies® generated using Ablynx's proprietary technology platform.
Final results of the randomized intergroup EORTC, LYSA (Lymphoma Study Association), FIL (Fondazione Italiana Linfomi) H10 trial presented at the 13th International Conference on Malignant Lymphoma in Lugano, Switzerland, on 19 June 2015 show that early FDG-PET ( 2-deoxy-2[F-18]fluoro-D-glucose positron emission tomography) adapted treatment improves the outcome of early FDG-PET-positive patients with stages I/II Hodgkin lymphoma.
Heart failure is a medical condition that results when the heart muscle is not strong enough to effectively circulate blood.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Mary K Holzinger, LCSW-C, CEAP 6040 Douglas Ave, New Market, MD 21774-6264 Ph: (301) 865-2226 | Mrs Mary K Holzinger, LCSW-C, CEAP 164 W Main St, Suite A, New Market, MD 21774 Ph: (301) 865-2226 |
News Archive
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that its ToleroMune(R) ragweed allergy T-cell vaccine achieved positive results in a recently completed phase II clinical trial. Ragweed allergy is particularly common in America, where it affects approximately 25% of the population. Circassia's latest clinical results follow two earlier successful phase II studies with the company's T-cell vaccine against cat allergy.
New research shows that patients who have had contact with the hospital due to serious glandular disease have a greater risk of subsequently developing depression.
Ablynx [Euronext Brussels: ABLX] and Spirogen Ltd. announce a research collaboration to evaluate the potential of a novel anti-cancer drug conjugate combining Spirogen's proprietary cytotoxic drugs, pyrrolobenzodiazepines (PBD), and associated linker technology, with Nanobodies® generated using Ablynx's proprietary technology platform.
Final results of the randomized intergroup EORTC, LYSA (Lymphoma Study Association), FIL (Fondazione Italiana Linfomi) H10 trial presented at the 13th International Conference on Malignant Lymphoma in Lugano, Switzerland, on 19 June 2015 show that early FDG-PET ( 2-deoxy-2[F-18]fluoro-D-glucose positron emission tomography) adapted treatment improves the outcome of early FDG-PET-positive patients with stages I/II Hodgkin lymphoma.
Heart failure is a medical condition that results when the heart muscle is not strong enough to effectively circulate blood.
› Verified 1 days ago
Ms. Paula Carolyn Bell, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10580 Edwardian Ln, New Market, MD 21774 Phone: 301-865-1417 Fax: 301-865-1417 | |
Margaret Ellsworth Terry, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 11670 Old National Pike, Suite 103, New Market, MD 21774 Phone: 301-865-2226 | |
Mrs. Shereen Anne Robinson, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5724 Heatherwood Ct, New Market, MD 21774 Phone: 301-662-5122 Fax: 301-865-6163 | |
Angela Kathryn Neal, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7256 Bodkin Way, New Market, MD 21774 Phone: 202-360-0647 | |
Ms. Cristine Marie Zocchi, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 125 W Main St, New Market, MD 21774 Phone: 240-236-4600 | |
Elizabeth Ann Cline, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 11670 Old National Pike Ste 103, New Market, MD 21774 Phone: 301-865-2226 | |
Angela Egger, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6780 Balmoral Rdg, New Market, MD 21774 Phone: 602-509-2110 |